Full Breakdown
Advanced CTE Linked to Increased Dementia Risk
2/20/2026, 10:24:59 PM
Study Findings on CTE and Dementia
A significant study conducted by the Boston University CTE Center has established a strong link between advanced chronic traumatic encephalopathy (CTE) and an increased risk of dementia. The research analyzed 614 brain donations from individuals with a history of repeated head trauma, revealing that those with stage IV CTE had a fourfold increase in the likelihood of developing dementia, while stage III CTE doubled that risk. The findings were published in the journal *Alzheimer’s & Dementia* on January 27, 2026.
CTE is characterized by the accumulation of tau protein in the brain, which differs from the pathology seen in Alzheimer's disease (AD). The study highlighted that many individuals diagnosed with dementia during their lives were misclassified, with 40% of those later found to have CTE initially diagnosed with Alzheimer's. This misdiagnosis underscores the necessity for improved diagnostic criteria that differentiate CTE from other neurodegenerative disorders.
Implications for Diagnosis and Treatment
The study's authors emphasized the importance of recognizing CTE as a distinct cause of dementia, advocating for its inclusion in the differential diagnosis of dementia, especially for individuals with a history of head trauma. Co-author Michael Alosco noted that the evidence contradicts the notion that CTE is a benign condition, stating, “This is the opposite of the experience of most patients and families.”
The researchers also called for the development of blood-based biomarkers to aid in the accurate diagnosis of CTE, which is currently only confirmable post-mortem. Alosco expressed hope that future studies could lead to effective treatments for cognitive symptoms associated with CTE.
Criticism and Opposition
Despite the study's robust findings, some experts have raised concerns regarding the lack of association between CTE and neurobehavioral symptoms, which are often expected in cases of traumatic encephalopathy. David Dodick, a neurologist not involved in the study, noted his surprise at this finding, suggesting that it could indicate potential for treating mood-related symptoms in CTE patients.
Official Statements & Responses
The study's authors have called for CTE to be formally recognized as an Alzheimer's-related dementia, which would facilitate unified funding and caregiving strategies. Alosco stated, “It is a cause of dementia, so I do think it should be formally recognized,” while Dodick concurred, emphasizing the need for legislative efforts to achieve this recognition.
Verbatim Quotes
- “Establishing that cognitive symptoms and dementia are outcomes of CTE moves us closer to being able to accurately detect and diagnose CTE during life, which is urgently needed,” — Michael Alosco, Associate Professor of Neurology, Boston University
- “There is a viewpoint out there that CTE is a benign brain disease; this is the opposite of the experience of most patients and families,” — Michael Alosco
- “From a funding and caregiving standpoint, it makes sense, at this time, to include CTE as an Alzheimer’s-related dementia.” — David Dodick, Chief Science and Medical Officer, Atria Health Institute
What's Next
Ongoing research aims to develop biomarkers for CTE, which could significantly enhance diagnostic accuracy and treatment options. The study was supported by the National Institutes of Health and other institutions, indicating a commitment to further understanding and addressing the implications of CTE on public health.
